首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   18504篇
  免费   1159篇
  国内免费   82篇
耳鼻咽喉   292篇
儿科学   580篇
妇产科学   430篇
基础医学   2494篇
口腔科学   354篇
临床医学   1539篇
内科学   4441篇
皮肤病学   597篇
神经病学   1673篇
特种医学   600篇
外科学   2336篇
综合类   74篇
一般理论   2篇
预防医学   1610篇
眼科学   290篇
药学   1102篇
中国医学   85篇
肿瘤学   1246篇
  2023年   168篇
  2022年   314篇
  2021年   679篇
  2020年   338篇
  2019年   551篇
  2018年   738篇
  2017年   438篇
  2016年   440篇
  2015年   535篇
  2014年   744篇
  2013年   884篇
  2012年   1226篇
  2011年   1240篇
  2010年   671篇
  2009年   668篇
  2008年   1007篇
  2007年   983篇
  2006年   967篇
  2005年   931篇
  2004年   870篇
  2003年   856篇
  2002年   779篇
  2001年   398篇
  2000年   443篇
  1999年   365篇
  1998年   125篇
  1997年   107篇
  1996年   129篇
  1995年   97篇
  1994年   85篇
  1993年   73篇
  1992年   202篇
  1991年   162篇
  1990年   167篇
  1989年   144篇
  1988年   139篇
  1987年   114篇
  1986年   99篇
  1985年   99篇
  1984年   72篇
  1983年   51篇
  1982年   30篇
  1981年   29篇
  1979年   54篇
  1978年   34篇
  1977年   31篇
  1976年   36篇
  1975年   41篇
  1974年   43篇
  1972年   29篇
排序方式: 共有10000条查询结果,搜索用时 27 毫秒
1.
Breast pseudoaneurysms after a core needle biopsy are a rare complication with a low incidence. However, it is important to be aware of the possibility of complications that require treatment.  相似文献   
2.
3.
4.
5.
Gangliocytic paragangliomas are rare tumors that almost exclusively occur within the second portion of the duodenum. Although these tumors generally have a benign clinical course, they have the potential to recur or metastasize to regional lymph nodes. The case report presented here describes a 57-year-old female patient with melena, progressive asthenia, anemia, and a mass in the second-third portion of the duodenum that was treated by local excision. The patient was diagnosed with a friable bleeding tumor. The histologic analysis showed that the tumor was a 4 cm gangliocytic paraganglioma without a malignant cell pattern. In the absence of local invasion or distant metastasis, endoscopic resection represents a feasible, curative therapy. Although endoscopic polypectomy is currently considered the treatment of choice, it is not recommended if the size of the tumor is > 3 cm and/or there is active or recent bleeding. Patients diagnosed with a gangliocytic paraganglioma should be closely followed-up for possible local recurrence.  相似文献   
6.
7.

Background

Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.

Materials and methods

Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.

Results

EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.

Conclusion

This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号